Meeder Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5
| Closed | -$1.66K | – | 949 |
|
|
2025
Q1 | $1.66K | Sell |
5
-2
| -29% | -$662 | ﹤0.01% | 877 |
|
|
2024
Q4 | $2.16K | Buy |
+7
| New | +$2.16K | ﹤0.01% | 886 |
|
|
2024
Q2 | – | Sell |
-10
| Closed | -$2.67K | – | 938 |
|
|
2024
Q1 | $2.67K | Buy |
+10
| New | +$2.67K | ﹤0.01% | 703 |
|
|
2021
Q3 | – | Sell |
-3,364
| Closed | -$328K | – | 2576 |
|
|
2021
Q2 | $328K | Buy |
+3,364
| New | +$328K | 0.02% | 621 |
|
|
2019
Q1 | – | Sell |
-557
| Closed | -$63K | – | 1790 |
|
|
2018
Q4 | $63K | Sell |
557
-5
| -0.9% | -$566 | 0.01% | 752 |
|
|
2018
Q3 | $120K | Buy |
562
+126
| +29% | +$26.9K | 0.01% | 607 |
|
|
2018
Q2 | $122K | Buy |
436
+326
| +296% | +$91.2K | 0.01% | 591 |
|
|
2018
Q1 | $13K | Buy |
110
+3
| +3% | +$355 | ﹤0.01% | 1000 |
|
|
2017
Q4 | $10K | Buy |
107
+90
| +529% | +$8.41K | ﹤0.01% | 1126 |
|
|
2017
Q3 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 1553 |
|